Protocol Summaries: GSK2637671A(Primary)
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| 115115 | phase 3 | Safety and immunogenicity study of a prime-boost schedule of GSK Biologicals' influenza vaccine GSK1562902A in children aged 3 to 17 years | Completed |